MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.8433
-0.0282 (-3.24%)
At close: May 8, 2026, 4:00 PM EDT
0.8500
+0.0067 (0.79%)
After-hours: May 8, 2026, 7:09 PM EDT
MaxCyte Employees
MaxCyte had 91 employees as of December 31, 2025. The number of employees decreased by 23 or -20.18% compared to the previous year.
Employees
91
Change (1Y)
-23
Growth (1Y)
-20.18%
Revenue / Employee
$362,923
Profits / Employee
-$490,440
Market Cap
90.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 91 | -23 | -20.18% |
| Dec 31, 2024 | 114 | -29 | -20.28% |
| Dec 31, 2023 | 143 | 18 | 14.40% |
| Dec 31, 2022 | 125 | 41 | 48.81% |
| Dec 31, 2021 | 84 | 19 | 29.23% |
| Mar 31, 2021 | 65 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 658 |
| Outset Medical | 310 |
| AVITA Medical | 226 |
| Rapid Micro Biosystems | 171 |
| Nano-X Imaging | 165 |
| Xtant Medical Holdings | 151 |
| LENSAR | 150 |
| Sera Prognostics | 72 |
MXCT News
- 10 days ago - MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 5 weeks ago - MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - MaxCyte price target lowered to $5 from $7 at Craig-Hallum - TheFly
- 6 weeks ago - MaxCyte Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - MaxCyte sees FY26 revenue $30M-$32M, consensus $38.41M - TheFly
- 6 weeks ago - MaxCyte reports Q4 EPS (9c), consensus (8c) - TheFly
- 6 weeks ago - MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance - GlobeNewsWire
- 6 weeks ago - MaxCyte appoints Parmeet Ahuja as CFO - TheFly